Company / Current Liabilities
enGene Holdings Inc. Current Liabilities History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$32.0M
FY2025
5-year range
$5.1M / $32.0M
FY2022-FY2025
Trend
+118.1%
vs FY2024
Sector context
#169 of 214
Health Care
What the data says
enGene Holdings Inc.'s current liabilities of $32M is lower than 79% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 3 consecutive years, from $5M in FY2022 to $32M in FY2025.
Based on SEC 10-K filings.
$32M in FY2025 with a 3-year CAGR of +84.4%.
Increased from $5M to $32M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +84.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 214This company $32.0M Sector average $1.6B
▼
-98.0% below sector average
Key checks
Key Insights
- enGene Holdings Inc.'s current liabilities has grown for 3 consecutive years.
- 3-year CAGR of +84.4%, indicating consistent growth.
- In FY2025, current liabilities increased 118.1% year-over-year.
- Ranks #169 out of 214 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $32.0M | +118.1% |
| FY2024 | $14.7M | +178.9% |
| FY2023 | $5.3M | +3.0% |
| FY2022 | $5.1M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026